Southwest Diabetes Symposium 2007

San Antonio, Texas
Friday, November 02, 2007

Southwest Diabetes Symposium 2007
Friday, November 02, 2007 7:30 AM -
Saturday, November 03, 2007 3:15 PM (Central Time)

Texas Diabetes Institute (TDI)
TDI Auditorium
701 S. Zarzamora Street
San Antonio, Texas 78207

Map and Directions
Program Goal

The Texas Diabetes Institute and The University of Texas Health Science Center at San Antonio,  Division of Diabetes are offering a comprehensive update on the management of Type 2 diabetes.

This course is offered to physicians and allied health professionals who are interested in the most recent advances concerning the pathogenesis and treatment of diabetes mellitus and its related microvascular and macrovascular complications.

This day-and-a-half interaction provides an intensive, practical, multidisciplinary approach to the treatment of hyperglycemia, dyslipidemia, hypertension, clinical nephropathy, retinopathy, autonomic neuropathy and obesity.

Speakers will present a rational therapeutic approach based upon sound pathophysiologic principles. All treatment guidelines will be based on the standards of care for diabetic patients, as published by the American Diabetes Association.

Registration Fee:

- $250 on or before October 5
- $275 after October 5, 2007
- $200 (UHS/UTHSCSA employee)

Objectives


The participants will be able to:
• Describe the link between glucose and risk of diabetes complications
• State the cardiovascular risk associated with diabetes
• List the key defects in the pathogenesis of Type 2 diabetes
• Describe the appropriate use of medications in the prevention of complications for diabetes
• Describe the appropriate use of insulin in Type 2 diabetes
• Discuss the link between diabetes and the metabolic syndrome
• State the current therapy for the treatment of dyslipidemia in people with diabetes
• Discuss current strategies for the prevention and treatment of diabetic nephropathy
• Describe the neuropathic complications associated with diabetes
• Recognize the link between obesity and diabetes and current thought on how to treat obesity
• Discuss current and future medications that may be used in the treatment of obesity
• Explain the etiology and treatment of Type 1 diabetes mellitus
• Identify the main areas of clinical research interest in the field of diabetes and its complications
• Understand the major clinical research methods and techniques used to evaluate new therapies
• Explain the causes of diabetic foot ulcers and state the signifi cant advances in treatment
• Explain how depression is associated with glycemic control
• Review the classifi cation of diabetic retinopathy
• Outline the clinical ocular signs that indicate immediate referral and treatment by an ophthalmologist

Agenda:

November 2:  
7:30 a.m. – 8:45 a.m
Registration and Continental Breakfast
8:45 a.m. – 9:00 a.m.
Welcome to the Texas Diabetes Institute
Theresa De La Haya, RN, MPH
9:00 a.m. –9:45 a.m
Type 1 Diabetes Mellitus:  What Does the Future Hold
Jerry Palmer, MD
9:45 a.m. – 10:30 a.m.
Advances in Insulin Therapy
Jerry Palmer, MD
10:30 a.m. – 10:40 a.m. 
Break
10:40 a.m. – 12:00 p.m.
Epidemiology and Pathogenesis of Type 2 Diabetes Mellitus
Ralph A. DeFronzo, MD
12:00 p.m. – 1:00 p.m.
Lunch (provided)/Research Update
Eugenio Cersosimo, MD, PhD and Nicolas Musi, MD, PhD
1:30 p.m. – 3:00 p.m
Treatment of Type 2 Diabetes –Oral Agents  &Exenatide

Ralph A. DeFronzo, MD
3:00 p.m. – 4:00 p.m.
Obesity:  Etiology and Therapeutic Strategies
George Bray, MD
4:00 p.m. – 4:20 p.m.
Break
4:20 p.m. – 5:15 p.m.
Atherosclerotic Cardiovascular Disease and Diabetes Mellitus

Robert Chilton, DO
   
November 3:  
7:30 a.m. –
8:00 a.m.
Registration and Continental Breakfast
8:00 a.m. – 9:00 a.m.
Beta Cell Failure and Prevention of Type 2 Diabetes: Can They Be Achieved?

Ralph A. DeFronzo, MD
9:00 a.m. – 10:00 a.m.
Diabetic Dyslipidemia
Charles A. Reasner, II, MD
10:00 a.m. – 10:15 a.m.
Break
10:15 a.m. – 11:15 a.m. 
Hypertension and Diabetes
Curtis Triplitt, PharmD
11:15 a.m. – 12:15 p.m.
Diabetic
Nephropathy:  Etiology and Therapy
Ralph A. DeFronzo, MD
12:15 p.m. – 1:15 p.m.
Lunch (provided)
1:15 p.m. – 2:00 p.m
Concurrent Sessions (1)  Coping with the Epidemic of Type 2 Diabetes and Obesity in Children
Daniel Hale, MD

Concurrent Sessions (2)  Diabetes and the Eye
Carlos Rosende, MD

Concurrent Sessions (3)  Pregnancy and Diabetes
Elly Xenakis, MD

2:15 p.m. – 3:00 p.m.
Concurrent Sessions (1)  Insulin Resistance (Metabolic) Syndrome
Charles A. Reasner, II, M.D.

Concurrent Sessions (2) Nutritional Therapy in the Management of Type 2 Diabetes
Patsy Parker, RD

Concurrent Sessions (3)  The Diabetic Foot
Javier LaFontaine, DPM

3:00 p.m. – 3:15 p.m.
Evaluation and Certificates

Cancellation Policy

Registrations cancelled a minimum of five (5) working days prior to the first day of class are eligible for a refund minus a $60.00 processing fee. Cancellation requests received after this time are not eligible for a refund. Texas Diabetes Institute reserves the right to cancel any class due to low enrollment.

 

Contact Information

  • Phone: 210-358-7398
    Email: ruby.reyes@uhs-sa.com

Payment Instructions

RegOnline® by Lanyon is the quick, easy and affordable online event registration and event management software for small and medium-sized events. The solution includes event websites, event marketing tools, mobile event apps, online registration forms, badge maker and more.